2016
DOI: 10.7314/apjcp.2016.17.3.879
|View full text |Cite
|
Sign up to set email alerts
|

Microchips and their Significance in Isolation of Circulating Tumor Cells and Monitoring of Cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 92 publications
0
6
0
Order By: Relevance
“…As a tumor grows, its genetic and epigenetic features alter as a result of microenvironment changes and, even, therapeutic pressure. Moreover, changes in the genetic and epigenetic features of cancer cells mutually have an impact on the cancer microenvironment (4)(5)(6)(7). The cancer microenvironment is composed of many players such as extracellular matrix (ECM), stromal cells, and tissue-specific cells.…”
Section: Introductionmentioning
confidence: 99%
“…As a tumor grows, its genetic and epigenetic features alter as a result of microenvironment changes and, even, therapeutic pressure. Moreover, changes in the genetic and epigenetic features of cancer cells mutually have an impact on the cancer microenvironment (4)(5)(6)(7). The cancer microenvironment is composed of many players such as extracellular matrix (ECM), stromal cells, and tissue-specific cells.…”
Section: Introductionmentioning
confidence: 99%
“…These occurrences lead to the regulation of gene expression which is involved in the tumor cell cycle, proliferation, survival, growth, differentiation, and motility. 19,20 S100A8/S100A9 stimulates the production of proinflammatory cytokines (tumor necrosis factor alpha Figure 1. (a) The structure of calprotectin (S100A8/S100A9); each calprotectin monomer consists of two Ca 2þ binding EF-hand motifs in the N-terminal and C-terminal of sequence which are connected by a linker region (hinge region).…”
Section: Introductionmentioning
confidence: 99%
“…Although there has been a progression towards figuring out the histological characteristics and molecular mechanisms underlying cancer development, studies showing favorable responses to available drugs continue to be rare. As a result, the survival chances of patients have not significantly improved (Siegel et al, 2013;Sahmani et al, 2016). A major obstacle for following a better treatment plan has been the heterogeneity of these cancers.…”
Section: Introductionmentioning
confidence: 99%